RSV: Clinicians Discuss Strategies to Deal with Vaccine Resistance
Drug Topics
JANUARY 17, 2024
A panel of clinicians gathered to address concerns and report preliminary findings around rates of RSV incidence, hospitalization, and vaccination.
Wed.Jan 17, 2024
187 
Psychedelic Pharmacists Association Is Working to Promote, Establish the Role of the Pharmacist in Psychedelic-Assisted Therapy
Pharmacy Times
JANUARY 17, 2024
The co-founders of PPA discuss the importance of advocacy work at this point in the development of the psychedelic medicine industry to help cement pharmacist’s role in the continuum of care.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Nonpharmaceutical Interventions Reduced Hospitalizations, Deaths in Early COVID-19 Pandemic
Drug Topics
JANUARY 17, 2024
Study authors noted the importance of their results as they apply to understanding the usefulness of intervention measures and preparing for future pandemics.
5 Key Potential Approvals for 2024
Pharmacy Times
JANUARY 17, 2024
Multiple sclerosis and pulmonary arterial hypertension are disease states expected to have new medications in the upcoming year
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT+: FDA clears AI skin cancer detector for primary care doctors to use
STAT
JANUARY 17, 2024
The Food and Drug Administration cleared an AI-powered device for detecting skin cancer on Wednesday, giving primary care physicians a new way to evaluate troubling skin spots. Around 5 million skin cancers are diagnosed each year in the United States. Skin cancer is common, but most types are not that deadly when caught early. The device, developed by a small company called DermaSensor, is handheld and uses light to examine suspicious moles on a cellular level.
General Catalyst's new health system company to acquire Summa Health
Fierce Healthcare
JANUARY 17, 2024
Venture capital firm General Catalyst is making good on its October promise to purchase a health system with about eight months left to spare. | The venture capital firm's deal would make the Ohio nonprofit a wholly owned subsidiary of the recently launched Health Assurance Transformation Corp. The deal still requires regulatory approval.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
13 health systems collaborate with high schools in $250M initiative to boost healthcare workforce
Fierce Healthcare
JANUARY 17, 2024
As the U.S. | The new program from Bloomberg Philanthropies and major systems like Mass General Brigham, HCA Healthcare and Northwell Health will build new or refurbish existing high schools in 10 urban and rural communities.
Opinion: The decline and fall of elite multispecialty medical groups
STAT
JANUARY 17, 2024
The failure of Geisinger Health System, which lost $842 million in 2022 and disappeared into a new Kaiser subsidiary called Risant, sent shockwaves through the health care community in the spring of 2023. Founded in 1919, Geisinger was in the vanguard of the so-called “value-based care” movement. It sponsored a regionally significant 600,000-member health plan and served as the home of an exceptionally high-quality 1,600-person multispecialty medical group.
Expert: Provider Status for Pharmacists ‘Could Be Possible in 2024’
Pharmacy Times
JANUARY 17, 2024
WIth 31% of the US population living in a health care provider shortage area, current bills in Congress look to broaden the scope of pharmacists’ role in patient care.
STAT+: At health care’s biggest investor conference, AI’s high hopes collided with skepticism
STAT
JANUARY 17, 2024
You didn’t need machine learning to make one prediction about the year’s biggest conference for health care investors, which was held in San Francisco last week. It was going to rain. Recursion, a biotechnology firm that uses machine learning for drug development and and which was announcing that it is rolling out AI-driven drug discovery software with tech giant Nvidia, decided to seize the moment.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Parent-led autism therapy provider Forta clinches $55M to expand practice, AI research
Fierce Healthcare
JANUARY 17, 2024
Forta, a family-powered autism therapy startup, has raised $55 million in a series A round. | Forta is trying to fill the gap in accessible therapy services for autism by training parents to become behavior technicians to treat their own kids.
A new, non-invasive test could help predict the quality of embryo used for IVF
STAT
JANUARY 17, 2024
Researchers from the University of California San Diego School of Medicine say a new method can better predict the quality of embryos used for in vitro fertilization, potentially raising the odds of a successful pregnancy for those relying on assisted reproductive technology. For people struggling with infertility, IVF — which involves retrieving eggs and fertilizing them in the lab before implanting embryos in the uterus — often provides hope.
Bayer CEO Bill Anderson makes his mark with major restructuring, 'significant' job cuts
Fierce Pharma
JANUARY 17, 2024
Bayer is launching a sweeping business overhaul as the German conglomerate sees “no viable alternative.” | Bayer is launching a sweeping business overhaul that will “come at the expense of many managerial employees,” as the German conglomerate sees “no viable alternative.
Cancer death rate continues to decline but new cases expected to top 2 million this year, study finds
Fierce Healthcare
JANUARY 17, 2024
Cancer deaths in the United States are falling, with more than 4 million fewer deaths since 1991. | Cancer deaths in the United States are falling, with more than 4 million fewer deaths since 1991. But, this progress is jeopardized by increasing incidence for 6 of the top 10 cancers as the projected number of new diagnoses now tops 2 million for the first time, according to new data from the American Cancer Society.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Women’s health gap estimated at $1trn in new report
pharmaphorum
JANUARY 17, 2024
The disparity in access to healthcare between women and men around the world is often talked about but has never been given a dollar value – until now.
STAT+: Hair loss is one of the most hated chemotherapy side effects. A new biotech hopes to prevent it
STAT
JANUARY 17, 2024
The chemotherapy Christine Ko was prescribed for her breast cancer is pretty much a guarantee for losing your hair. The intervention her doctors offered to prevent the hair loss was a cold cap that, cooled to 32 degrees Fahrenheit, would turn her scalp into an icy crown. But, to her, it wasn’t much of an option. “It would cost about $2,000, and it’s about 50% effective.
New anti-smoking drug set for rapid NHS rollout
pharmaphorum
JANUARY 17, 2024
Oral cytisine therapy for smoking cessation from Consilient Health will launch in the UK next week, helping to alleviate a shortage of prescription drugs to help people quit
Blue Cross NC closes purchase of 55 FastMed urgent care centers in state
Fierce Healthcare
JANUARY 17, 2024
Blue Cross and Blue Shield of North Carolina has closed a deal to scoop up 55 FastMed urgent care clinics operating in the Tarheel State. | Blue Cross and Blue Shield of North Carolina has closed a deal to scoop up 55 FastMed urgent care clinics operating in the Tarheel State.
Why Scotland is well-positioned to lead in advanced therapies for complex diseases
pharmaphorum
JANUARY 17, 2024
Scotland's expertise in advanced therapies, combined with its robust healthcare system and strong research infrastructure, positions it as a leader in tackling complex diseases such as lung, liver, and vascular disorders. Discover why Scotland is at the forefront of innovation and advancements in this field.
Study: A Plant-Based Diet Could Reduce COVID-19 Infection
Pharmacy Times
JANUARY 17, 2024
Individuals that lived on a majority plant-based or vegetarian/vegan diet were 39% less likely to be infected with COVID-19.
This week in clinical trials: 8th-12th January
pharmaphorum
JANUARY 17, 2024
Stay up to date on the latest clinical trials happening in the week of 8th-12th January. Get information on trials for Lytix Biopharma's Verrica, Celletcar, Ariceum, Dermavant, BI, and more.
FDA Grants Breakthrough Device Designation to Prescription Digital Therapeutic App for Schizophrenia
Drug Topics
JANUARY 17, 2024
The CONVOKE study is investigating the effectiveness of the smartphone app as a therapy for negative symptoms of schizophrenia among adults.
US agency nixes Seagen patent, handing Daiichi Sankyo a win in long-running Enhertu entanglement
Fierce Pharma
JANUARY 17, 2024
After years of patent litigation between cancer drug developers Daiichi Sankyo and Seagen, the U.S. Patent and Trademark office (U.S. PTO) has handed Daiichi the latest win in the saga. | After a Texas jury sided with Seagen a patent spat, the U.S. Patent and Trademark Office has invalidated the patent in question.
Empagliflozin recommended by NICE as add-on to standard care in chronic kidney disease
Hospital Pharmacy Europe
JANUARY 17, 2024
The National Institute for Health and Care Excellence (NICE) has recommended that empagliflozin can be used as an option for treating chronic kidney disease (CKD) in adults under some circumstances. It has to be prescribed as an add-on to standard care including the highest tolerated dose of angiotensin-converting-enzyme inhibitor or angiotensin-receptor blocker unless contraindicated, a Technology Appraisal has stated.
STAT+: Testosterone didn’t lower fracture risk in a surprising new study. Researchers have theories about why
STAT
JANUARY 17, 2024
Testosterone is essential for bone health in men. It helps maintain bone density and improve bone microarchitecture, preventing fractures. So treating older men with hypogonadism — a condition that causes low testosterone levels — with the hormone should decrease their likelihood of getting fractures, right? Surprisingly not, according to a study published Wednesday in the New England Journal of Medicine.
Medicines regulators urge caution as new evidence links paternal valproate use and autism risk
Hospital Pharmacy Europe
JANUARY 17, 2024
The UK and European medicines regulators are considering new evidence suggesting that children whose fathers took valproate during the three months before conception are at increased risk of neurodevelopmental disorders such as autism. A new study, commissioned by the European Medicines Agency (EMA), found that around five in 100 children born to fathers treated taking valproate around conception were diagnosed with a disorder, compared with three in 100 children with fathers who took other anti
Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO
pharmaphorum
JANUARY 17, 2024
The US patent office has invalidated the only Seagen patent cited in a lawsuit claiming infringement by Daiichi Sankyo’s breast cancer therapy Enhertu.
Free Drug Interactions Crossword Puzzle
Med Ed 101
JANUARY 17, 2024
In the challenging world of pharmacology, recognizing drug interactions is paramount to ensuring patient safety and optimal treatment outcomes. To make this complex subject more engaging and accessible, we’ve introduced a unique approach – a crossword puzzle that challenges both healthcare professionals and enthusiasts to navigate the labyrinth of drug interactions.
How new technologies help keep brand planning simple
pharmaphorum
JANUARY 17, 2024
New technologies have revolutionised brand planning and strategy development, making it easier than ever to create and execute effective brand plans. Explore how these technologies simplify the brand planning process and maximise success.
With $1.2B stock sale, GSK offloads more of its stake in consumer health spinoff Haleon
Fierce Pharma
JANUARY 17, 2024
GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in 2022. | GSK is sticking to its plan to gradually monetize its stake in Haleon, the consumer health business the British pharma giant spun off in 2022.
STAT+: Pharmalittle: We’re reading about a CRISPR approval, selling meds directly to patients, and more
STAT
JANUARY 17, 2024
Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today is butter pecan, a household favorite — and get started. Meanwhile, do keep us in mind if you hear anything interesting.
Beetroot Juice Supplement May Be Beneficial for Patients With COPD
Pharmacy Times
JANUARY 17, 2024
A 12-week supplement improved systolic blood pressure in this patient group more than placebo.
Ban on Apple Watches with pulse oximetry renews in US
pharmaphorum
JANUARY 17, 2024
US federal court renews ban on Apple Watches with blood oxygen feature that infringes patents held by Masimo, but tech giant says it has a workaround
9 medications that can help with nerve pain
The Checkup by Singlecare
JANUARY 17, 2024
Nerve pain, also known as neuropathic pain , is a type of pain that results from nerve damage to your nervous system, which includes your brain, spinal cord, and peripheral nerves. Nerve pain in the peripheral nerves is termed neuralgia and can result from bodily injury or from peripheral neuropathy due to an illness such as HIV or shingles or a medical condition like diabetes.
Let's personalize your content